Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-12-16

FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for AMNESTEEM (isotretinoin) from Mylan Pharmaceuticals, indicating a labeling-related update for this generic produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMNESTEEM (isotretinoin)

Snippet

SUPPL AP for AMNESTEEM (ISOTRETINOIN)